Contribution and Interaction of the Low-density Lipoprotein Cholesterol to High-density Lipoprotein Cholesterol Ratio and Triglyceride to Diabetes in Hypertensive Patients: A Cross-sectional Study

Overview

Journal J Diabetes Investig

Specialty Endocrinology

Date 2018 Apr 26

PMID 29694714

Citations 15

Authors

Mengyang Hong

Yan Ling

Zhiqiang Lu

Ying Liu

Ping Gu

Jiaqing Shao

Xin Gao

Xiaomu Li

Affiliations

Soon will be listed here.

Abstract

Aims/introduction: Hypertension is one of the most significant risk factors for diabetes. The present study aimed to investigate the associations of lipid profiles, including the ratio of low-density lipoprotein cholesterol (LDL-C)-to-high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) levels, as well as their interactions, with type 2 diabetes in hypertensive patients.

Materials And Methods: Hypertensive patients without a history of diabetes and hypolipidemic agents were enrolled continuously at the Hypertension Clinic, Zhongshan Hospital, Fudan University (Shanghai, China) from 2014 to 2016. General clinical data, including body mass index, blood pressure, fasting glucose and 2-h post-load glucose levels, and lipid profiles, were collected. The LDL-C/HDL-C ratio, TG/HDL-C ratio and TC/HDL-C ratio were separately calculated. Statistical analyses were carried out by using SPSS software (version 13.0).

Results: In total, 935 hypertensive patients were included, of which 114 patients (12.2%) were diagnosed with diabetes. After multivariate adjustments, the LDL-C/HDL-C ratio and TG levels had the most significant and independent associations with diabetes. In the multivariate logistic regression, the LDL-C/HDL-C ratio and TG were independently associated with diabetes. After the interaction variable was included, the LDL-C/HDL-C ratio remained independently associated with diabetes, but TG was replaced by TG*LDL-C/HDL-C.

Conclusions: In conclusion, elevated LDL-C/HDL-C ratios and TG levels were associated with diabetes in patients with hypertension, with an interactive effect of the LDL-C/HDL-C ratio and TG on diabetes in the hypertensive population.

Citing Articles

Association between lipid ratios and sarcopenia and the mediating roles of inflammatory biomarkers in a cross-sectional study from NHANES 2011-2018.

Yin X, Song H, Chen H, Yang X, Zhang T Sci Rep. 2025; 15(1):6617.

PMID: 39994278 PMC: 11850801. DOI: 10.1038/s41598-025-90131-y.

The role of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (nhhr) in prediabetes progression and the mediating effect of BMI: a longitudinal study in China.

Wen S, Li J, Xie Z, Chen X, Li J, Lin X Diabetol Metab Syndr. 2025; 17(1):67.

PMID: 39987453 PMC: 11847345. DOI: 10.1186/s13098-025-01637-4.

Association Between Nontraditional Lipid Profiles and the Risk of Type 2 Diabetes Mellitus in Chinese Adults With Hypertension: Findings From the China Hypertension Registry Study.

Tao Y, Wang T, Zhou W, Zhu L, Yu C, Li J J Clin Hypertens (Greenwich). 2024; 27(1):e14927.

PMID: 39549245 PMC: 11771795. DOI: 10.1111/jch.14927.

The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio with type 2 diabetes mellitus: recent findings from NHANES 2007-2018.

Tan M, Weng L, Yang Z, Zhu S, Wu S, Su J Lipids Health Dis. 2024; 23(1):151.

PMID: 38773578 PMC: 11106869. DOI: 10.1186/s12944-024-02143-8.

Lipids as potential mediators linking body mass index to diabetes: evidence from a mediation analysis based on the NAGALA cohort.

Lu S, Wang Q, Lu H, Kuang M, Zhang M, Sheng G BMC Endocr Disord. 2024; 24(1):66.

PMID: 38730299 PMC: 11083816. DOI: 10.1186/s12902-024-01594-5.

References

Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S . Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults. Lipids Health Dis. 2010; 9:138. PMC: 3014951. DOI: 10.1186/1476-511X-9-138. View

Tenenbaum A, Fisman E, Boyko V, Benderly M, Tanne D, Haim M . Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate. Arch Intern Med. 2006; 166(7):737-41. DOI: 10.1001/archinte.166.7.737. View

Xia F, Gao X, Kwan E, Lam P, Chan L, Sy K . Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. J Biol Chem. 2004; 279(23):24685-91. DOI: 10.1074/jbc.M314314200. View

Puavilai G, Chanprasertyotin S, Sriphrapradaeng A . Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World.... Diabetes Res Clin Pract. 1999; 44(1):21-6. DOI: 10.1016/s0168-8227(99)00008-x. View

Abderrahmani A, Niederhauser G, Favre D, Abdelli S, Ferdaoussi M, Yang J . Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells. Diabetologia. 2007; 50(6):1304-14. DOI: 10.1007/s00125-007-0642-z. View

Vikman J, Jimenez-Feltstrom J, Nyman P, Thelin J, Eliasson L . Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol. FASEB J. 2008; 23(1):58-67. DOI: 10.1096/fj.08-105734. View

Roehrich M, Mooser V, Lenain V, Herz J, Nimpf J, Azhar S . Insulin-secreting beta-cell dysfunction induced by human lipoproteins. J Biol Chem. 2003; 278(20):18368-75. DOI: 10.1074/jbc.M300102200. View

Izzo R, de Simone G, Chinali M, Iaccarino G, Trimarco V, Rozza F . Insufficient control of blood pressure and incident diabetes. Diabetes Care. 2009; 32(5):845-50. PMC: 2671117. DOI: 10.2337/dc08-1881. View

Kramer C, von Muhlen D, Barrett-Connor E . Mid-life blood pressure levels and the 8-year incidence of type 2 diabetes mellitus: the Rancho Bernardo Study. J Hum Hypertens. 2009; 24(8):519-24. PMC: 2888977. DOI: 10.1038/jhh.2009.103. View

10.

Kimura T, Itoh T, Fusazaki T, Matsui H, Sugawara S, Ogino Y . Low-density lipoprotein-cholesterol/high-density lipoprotein-cholesterol ratio predicts lipid-rich coronary plaque in patients with coronary artery disease--integrated-backscatter intravascular ultrasound study. Circ J. 2010; 74(7):1392-8. DOI: 10.1253/circj.cj-09-0849. View

11.

Drew B, Duffy S, Formosa M, Natoli A, Henstridge D, Penfold S . High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation. 2009; 119(15):2103-11. DOI: 10.1161/CIRCULATIONAHA.108.843219. View

12.

Enomoto M, Adachi H, Hirai Y, Fukami A, Satoh A, Otsuka M . LDL-C/HDL-C Ratio Predicts Carotid Intima-Media Thickness Progression Better Than HDL-C or LDL-C Alone. J Lipids. 2011; 2011():549137. PMC: 3136137. DOI: 10.1155/2011/549137. View

13.

Ho C, Jap T . Do smoking and diabetes change the hemostatic parameters?--a study in the Chinese people. Thromb Res. 1994; 76(6):569-76. DOI: 10.1016/0049-3848(94)90286-0. View

14.

Love-Osborne K, Butler N, Gao D, Zeitler P . Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetes. Pediatr Diabetes. 2006; 7(4):205-10. DOI: 10.1111/j.1399-5448.2006.00179.x. View

15.

Elliott W, Meyer P . Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007; 369(9557):201-7. DOI: 10.1016/S0140-6736(07)60108-1. View

16.

Sung K, Park H, Kim M, Reaven G . Metabolic markers associated with insulin resistance predict type 2 diabetes in Koreans with normal blood pressure or prehypertension. Cardiovasc Diabetol. 2016; 15:47. PMC: 4802716. DOI: 10.1186/s12933-016-0368-7. View

17.

Rutti S, Ehses J, Sibler R, Prazak R, Rohrer L, Georgopoulos S . Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells. Endocrinology. 2009; 150(10):4521-30. DOI: 10.1210/en.2009-0252. View

18.

Ishikawa M, Iwasaki Y, Yatoh S, Kato T, Kumadaki S, Inoue N . Cholesterol accumulation and diabetes in pancreatic beta-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity. J Lipid Res. 2008; 49(12):2524-34. DOI: 10.1194/jlr.M800238-JLR200. View

19.

Jones I, Swai A, Taylor R, Miller M, Laker M, Alberti K . Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM. Diabetes Care. 1990; 13(8):855-63. DOI: 10.2337/diacare.13.8.855. View

20.

Conroy R, Pyorala K, Fitzgerald A, Sans S, Menotti A, De Backer G . Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24(11):987-1003. DOI: 10.1016/s0195-668x(03)00114-3. View